Patents by Inventor Young Hyun Na

Young Hyun Na has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Railless variable seatback type rear seat
    Patent number: 11970090
    Abstract: A railess variable seatback type rear seat includes: a linear movement device configured to convert a rotation of a motor into a linear movement; a sliding movement device configured to convert the linear movement into a sliding movement in which a seat cushion is pushed forward or backward; and a reclining angle change device configured to convert the sliding movement into a reclining movement, and to fold a seatback, which is connected to the seat cushion, forward or to recline the seatback backward.
    Type: Grant
    Filed: July 20, 2021
    Date of Patent: April 30, 2024
    Assignees: HYUNDAI MOTOR COMPANY, Kia Corporation, Daechang Seat Co.,LTD-Dongtan, Hyundai Transys Inc.
    Inventors: Seung-Hyun Kim, Sang-Hyun Lee, Min-Ju Lee, Byung-Yong Choi, Chan-Ho Jung, Seon-Chae Na, Young-Woon Choi, Jae-Jin Lee, Dong-Hwan Kim, In-Chang Hwang
  • COMPOSITION FOR INHIBITING GROWTH OF SARS-COV-2 AND METHOD OF PREPARING THE SAME
    Publication number: 20220119381
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Application
    Filed: November 30, 2020
    Publication date: April 21, 2022
    Applicants: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun NA, Kyung Pyo KANG, Jin Hwan JUN, Geon GO, Hyeon Jun NA, Sang Jin KANG, Young Hyun NA, Se Jin YOON, Su Ji NA
  • Composition for inhibiting growth of SARS-CoV-2 and method of preparing the same
    Patent number: 11292789
    Abstract: Disclosed is a composition for inhibiting the growth of virus. More particularly, the composition for inhibiting the growth of virus includes MDPX-V2021 represented by Formula 1, wherein MDPX-V2021 serves to inhibit a post-translational modification (PTM) stage in cells after SARS-CoV-2 penetrates into the body.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: April 5, 2022
    Assignees: Medicare Pharmaceuticals Inc., MEDICARE LC.
    Inventors: Do Hyun Na, Kyung Pyo Kang, Jin Hwan Jun, Geon Go, Hyeon Jun Na, Sang Jin Kang, Young Hyun Na, Se Jin Yoon, Su Ji Na